Probiotics 2000;14:1625–9.
66. Armuzzi A, Cremonini F, Bartolozzi F, et al., The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy, Aliment Pharmacol Ther, 2001;15:163–9.
67. Armuzzi A, Cremonini F, Ojetti V, et al., Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study, Digestion, 2001;63:1–7.
68. Cremonini F, Di Caro S, Covino M, et al., Effect of different probiotic preparations on anti-Helicobacter pylori therapyrelated side effects: a parallel group, triple blind, placebo-controlled study, Am J Gastroenterol, 2002;97:2744–9.
69. Sheu B, Wu J, Lo C, et al., Impact of supplement with Lactobacillus- and Bifidobacterium-containing yoghurt on triple therapy for Helicobacter pylori eradication, Aliment Pharmacol Ther, 2002;16:1669–75.
70. Guo JB, Yang PF, Wang MT, The application of clostridium to the eradication of Helicobacter pylori, Chin J Celiopathy, 2004;4:163–5.
71. Nista EC, Candelli M, Cremonini F, et al., Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial, Aliment Pharmacol Ther, 2004;20:1181–8.
72. Tursi A, Brandimarte G, Giorgetti GM, Modeo ME, Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection, Med Sci Monit, 2004;10:662–6.
73. Myllyluoma E, Veijola L, Ahlroos T, et al., Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy-a placebo-controlled, double-blind, randomized pilot study, Aliment Pharmacol Ther, 2005;21: 1263–72.
74. Cao YJ, Qu CM, Yuan Q, et al., Control of intestinal flora alteration induced by eradication therapy of Helicobacter pylori infection in the elders, Chin J Gastroenterol Hepatol, 2005;14:195–9.
75. Sykora J, Valeckova K, Amlerova J, et al., Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized, double-blind study, J Clin Gastroenterol, 2005;39:692–8.
76. Goldman CG, Barrado DA, Balcarce N, et al., Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children, Nutrition, 2006;22:984–8.
77. Lionetti E, Miniello VL, Castellaneta SP, et al., Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial, Aliment Pharmacol Ther, 2006;24:1461–8.
78. Cindoruk M, Erkan G, Karakan T, et al., Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study, Helicobacter, 2007;12:309–16.
79. Park SK, Park DI, Choi JS, et al., The effect of probiotics on Helicobacter pylori eradication, Hepatogastroenterology, 2007;54:2032–6.
80. Kim MN, Kim N, Lee SH, et al., The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication, Helicobacter, 2008;13:261–8.
81. Hurduc V, Plesca D, Dragomir D, et al., A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children, Acta Paediatr, 2009;98:127–31.
82. Szajewska H, Albrecht P, Topczewska-Cabanek A, Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children, J Pediatr Gastroenterol Nutr, 2009;48:431–6.
83. De Bortoli N, Leonardi G, Ciancia E, et al., Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics, Am J Gastroenterol, 2007;102:951–6.
84. Duman DG, Ozdemir F, Birben E, et al., Efficacy and safety of Saccharomyces boulardii in prevention of antibioticassociated diarrhea due to Helicobacter pylori eradication, Eur J Gastroenterol Hepatol, 2005;17:1357–61.
85. Imase K, Takahashi M, Tanaka A, et al., Efficacy of Clostridium butyricum preparation concomitantly with Helicobacter pylori eradication therapy in relation to changes in the intestinal microbiota, Microbiol Immunol, 2008;52:156–61.
86. Plummer SF, Garaiova I, Sarvotham T, et al., Effects of probiotics on the composition of the intestinal microbiota following antibiotic therapy, Int J Antimicrob Agents, 2005;26:69–74.
128
EUROPEAN GASTROENTEROLOGY & HEPATOLOGY REVIEW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84